A prospective, active haemovigilance study with combined cohort analysis of 19 175 transfusions of platelet components prepared with amotosalen– UVA photochemical treatment-Reference-Cited by-同舟云学术

A prospective, active haemovigilance study with combined cohort analysis of 19 175 transfusions of platelet components prepared with amotosalen– UVA photochemical treatment

Published:2015-05-15 Issue:4 Volume:109 Page:343-352
ISSN:0042-9007
Container-title:Vox Sanguinis
language:en
Short-container-title:Vox Sang

Author:

Knutson F.¹,Osselaer J.²,Pierelli L.³,Lozano M.⁴^ORCID,Cid J.⁴,Tardivel R.⁵,Garraud O.⁶,Hervig T.⁷,Domanovic D.⁸,Cukjati M.⁸,Gudmundson S.⁹,Hjalmarsdottir I. B.⁹,Castrillo A.¹⁰,Gonzalez R.¹⁰,Brihante D.¹¹,Santos M.¹¹,Schlenke P.¹²,Elliott A.¹³,Lin J.‐S.¹³,Tappe D.¹³,Stassinopoulos A.¹³,Green J.¹³,Corash L.¹³

Affiliation:

1. Department of Immunology, Genetics, and Pathology Uppsala University Uppsala Sweden

2. Cliniques Universitaires de Mont Godinne Universite Catholique de Louvain Yvoir Belgium

3. Department of Experimental Medicine Sapienza University of Roma Rome Italy

4. Department of Hemotherapy and Hemostasis CDB IDIBAPS Hospital Clinic Barcelona Spain

5. EFS Bretagne Rennes France

6. EFS Auvergne Loire St. Etienne France

7. Department of Immunology and Transfusion Medicine University of Bergen Bergen Norway

8. Blood Transfusion Centre of Slovenia Ljubljana Slovenia

9. Blood Bank National University Hospital Reykjavik Iceland

10. Transfusion Centre of Galicia Santiago de Compostela Spain

11. Servico de Imuno‐Hemoterapia Instituto Portugues de Oncologia de Lisboa Lisbon Portugal

12. Department of Blood Group Serology and Transfusion Medicine Medical University of Graz Graz Austria

13. Cerus Corporation Concord CA USA

Funder

Cerus Corporation

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/vox.12287

Reference27 articles.

1. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial

2. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial

3. Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set

4. http://www.who.int/bloodsafety/haemovigilance/en/Accession date 10 April 2015.

5. Haemovigilance: an effective tool for improving transfusion practice

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood Component Therapy and Massive Transfusion;Critical Care Obstetrics;2024-04

2. Evaluation of the efficacy and safety of amustaline/glutathione pathogen-reduced RBCs in complex cardiac surgery: the Red Cell Pathogen Inactivation (ReCePI) study—protocol for a phase 3, randomized, controlled trial;Trials;2023-12-11

3. Posttransfusion sepsis attributable to bacterial contamination in platelet collection set manufacturing, United States;Transfusion;2023-11

4. Transfusion‐associated adverse events incidence and severity after the implementation of an active hemovigilance program with 24 h follow‐up. A prospective cohort study;Transfusion;2023-09-15

5. Expanding applications of allogeneic platelets, platelet lysates, and platelet extracellular vesicles in cell therapy, regenerative medicine, and targeted drug delivery;Journal of Biomedical Science;2023-09-14